Remmers John E, Topor Zbigniew, Grosse Joshua, Vranjes Nikola, Mosca Erin V, Brant Rollin, Bruehlmann Sabina, Charkhandeh Shouresh, Zareian Jahromi Seyed Abdolali
University of Calgary, Calgary, Canada.
Zephyr Sleep Technologies, Calgary, Canada.
J Clin Sleep Med. 2017 Jul 15;13(7):871-880. doi: 10.5664/jcsm.6656.
Mandibular protruding oral appliances represent a potentially important therapy for obstructive sleep apnea (OSA). However, their clinical utility is limited by a less-than-ideal efficacy rate and uncertainty regarding an efficacious mandibular position, pointing to the need for a tool to assist in delivery of the therapy. The current study assesses the ability to prospectively identify therapeutic responders and determine an efficacious mandibular position.
Individuals (n = 202) with OSA participated in a blinded, 2-part investigation. A system for identifying therapeutic responders was developed in part 1 (n = 149); the predictive accuracy of this system was prospectively evaluated on a new population in part 2 (n = 53). Each participant underwent a 2-night, in-home feedback-controlled mandibular positioner (FCMP) test, followed by treatment with a custom oral appliance and an outcome study with the oral appliance in place. A machine learning classification system was trained to predict therapeutic outcome on data obtained from FCMP studies on part 1 participants. The accuracy of this trained system was then evaluated on part 2 participants by examining the agreement between prospectively predicted outcome and observed outcome. A predicted efficacious mandibular position was derived from each FCMP study.
Predictive accuracy was as follows: sensitivity 85%; specificity 93%; positive predictive value 97%; and negative predictive value 72%. Of participants correctly predicted to respond to therapy, the predicted mandibular protrusive position proved efficacious in 86% of cases.
An unattended, in-home FCMP test prospectively identifies individuals with OSA who will respond to oral appliance therapy and provides an efficacious mandibular position.
The trial that this study reports on is registered on www.clinicaltrials.gov, ID NCT03011762, study name: Feasibility and Predictive Accuracy of an In-Home Computer Controlled Mandibular Positioner in Identifying Favourable Candidates for Oral Appliance Therapy.
下颌前突口腔矫治器是阻塞性睡眠呼吸暂停(OSA)一种潜在的重要治疗方法。然而,其临床效用受到疗效不理想以及有效下颌位置不确定的限制,这表明需要一种工具来辅助该治疗的实施。本研究评估了前瞻性识别治疗反应者以及确定有效下颌位置的能力。
202例阻塞性睡眠呼吸暂停患者参与了一项双盲、分为两部分的研究。在第一部分(n = 149)中开发了一种识别治疗反应者的系统;该系统的预测准确性在第二部分(n = 53)的新人群中进行了前瞻性评估。每位参与者都进行了为期两晚的家庭反馈控制下颌定位器(FCMP)测试,随后使用定制口腔矫治器进行治疗,并对佩戴该口腔矫治器的情况进行结果研究。基于从第一部分参与者的FCMP研究中获得的数据,训练了一个机器学习分类系统来预测治疗结果。然后通过检查前瞻性预测结果与观察结果之间的一致性,对第二部分参与者评估该训练系统的准确性。从每项FCMP研究中得出预测的有效下颌位置。
预测准确性如下:敏感性85%;特异性93%;阳性预测值97%;阴性预测值72%。在被正确预测对治疗有反应的参与者中,预测的下颌前突位置在86%的病例中被证明是有效的。
一项无人监督的家庭FCMP测试可前瞻性地识别出对口腔矫治器治疗有反应的阻塞性睡眠呼吸暂停患者,并提供有效的下颌位置。
本研究报告的试验已在www.clinicaltrials.gov上注册,ID为NCT03011762,研究名称:家庭计算机控制下颌定位器在识别口腔矫治器治疗合适候选人中的可行性和预测准确性。